Recent studies show that PD-1 blockade primarily expands Tpex cells (200, 201), whereas Ttex, despite their limited proliferative capacity, can transiently support tumor control through short-lived cytotoxic activity (14, 187). The gene discussed is PDCD1; the disease is neoplasm.